Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.businesswire.com/news/home/20210301005231/en/Lantheus-Announces-Publication-of-PyL%E2%84%A2-18F-DCFPyL-Results-from-Pivotal-Studies#:~:text=(NASDAQ%3A%20LNTH)%20(Lantheus,studies%20for%20PyL%E2%84%A2%2C%20an
https://www.urotoday.com/recent-abstracts/urologic-oncology/prostate-cancer/126532-pyl-18f-dcfpyl-lantheus-psma-targeted-prostate-cancer-imaging-agent-to-be-used-in-point-biopharma-s-psma-targeted-radioligand-therapeutic-phase-3-trial-in-patients-with-metastatic-castration-resistant-prostate-cancer.html
https://seekingalpha.com/news/3618383-lantheus-files-u-s-application-for-pet-imaging-agent-for-prostate-cancer